3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 3
1
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Endocrine
2
Conditions
Multiple Endocrine Neoplasia Type 1
96
Pituitary Neoplasms
57
Neuroendocrine Tumors
50
Thyroid Cancer, Papillary
42
Thyroid Neoplasms
16
Obesity
15
Pheochromocytoma
14
Overweight
11
Adrenal Gland Neoplasms
10
Weight Loss
9
Paraganglioma
9
Carcinoma, Neuroendocrine
9
Pancreatic Neoplasms
8
Prostatic Neoplasms
7
Motor Activity
7
Insulinoma
7
Gastrointestinal Neoplasms
7
Brain Neoplasms
7
Adrenocortical Adenoma
7
Acquired Immunodeficiency Syndrome
7
Neoplasm Metastasis
6
Hyperaldosteronism
6
Carcinoma, Medullary
6
Stomach Neoplasms
5
Osteoporosis
5
Neoplasms
5
Meningioma
5
Liver Neoplasms
5
Insulin Resistance
5
HIV Infections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Adrenal Gland Diseases
×
Endocrine
×
Clear all
NCT01676025
2017-10-06
PRA
Seoul National University Hospital
Phase NA
Completed
83 enrolled
NCT02618694
2017-03-03
PostLapAdrnl
Suez Canal University
Phase NA
Completed
13 enrolled